Cencora's EBIT per Share for the
three
months ended in Dec. 2023 was $4.17.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $12.91.
During the past 12 months, the average EBIT per Share Growth Rate of Cencora was 6.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 9.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 12.00% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 11.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Cencora's EBIT per Share or its related term are showing as below:
COR'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -29.5 Med: 11.1 Max: 25.7
Current: 9.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Cencora was 25.70% per year. The lowest was -29.50% per year. And the median was 11.10% per year.
COR's 3-Year EBIT Growth Rate is ranked better than 55.56% of 81
companies
in the Medical Distribution industry
Industry Median: 6.9
vs COR: 9.70
Cencora's EBIT for the
three
months ended in Dec. 2023 was $842 Mil.
Cencora EBIT per Share Historical Data
The historical data trend for Cencora's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.91
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cencora (NYSE:COR) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Cencora EBIT per Share Related Terms
Thank you for viewing the detailed overview of Cencora's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COR has been successfully added to your 